Benitec Biopharma Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureOct 5 →Insiders4 insiders bought $22.4M in 14 open-market buys. No sales.→HoldersMontanova Capital 33.6%Nantahala 8.6%Jupiter Topco 7.2%→PeersClosest companies: SDEV, IMMX, FJET→
From the filings
Figures
- Net income
- −$45.5Mlast 12 months
- Operating cash flow
- −$16.5Mlast 12 months
- Cash and equivalents
- $180.0Mat the last balance sheet
- Shares outstanding
- 34.4M shareson issue